Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 5000.00 | 1743.19 | 6298.00 | 6230.25 | 1.0113 | 1.0124 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 6193.00 | 6230.25 | 0.9940 | 0.9933 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 5000.00 | 1743.19 | 6000.33 | 6230.25 | 0.9633 | 0.9594 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 5968.33 | 6230.25 | 0.9582 | 0.9542 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 5000.00 | 1743.19 | 4133.67 | 6230.25 | 0.6635 | 0.5997 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 5000.00 | 1743.19 | 3474.67 | 6230.25 | 0.5579 | 0.4556 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 112.67 | 116.08 | 0.9774 | 1.0246 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 156.25 | 71.09 | 133.33 | 116.08 | 1.1527 | 1.5051 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 152.83 | 116.08 | 1.3158 | 1.9926 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 156.25 | 71.09 | 155.83 | 116.08 | 1.3504 | 2.2686 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 138.33 | 116.08 | 1.1986 | 1.7224 |
| BT-20 | Erlotinib | 1 | uM | 9 | 156.25 | 71.09 | 126.83 | 116.08 | 1.0955 | 1.3153 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 132.17 | 116.08 | 1.1371 | 1.4394 |
| BT-20 | Erlotinib | 10 | uM | 9 | 156.25 | 71.09 | 97.00 | 116.08 | 0.8335 | 0.5642 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 272.67 | 116.08 | 2.3641 | 6.5506 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 322.33 | 286.54 | 1.1207 | 1.2643 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 312.50 | 153.73 | 343.17 | 286.54 | 1.2120 | 1.5582 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 367.17 | 286.54 | 1.2674 | 1.5792 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 312.50 | 153.73 | 303.50 | 286.54 | 1.0743 | 1.2312 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 315.83 | 286.54 | 1.1017 | 1.2394 |
| BT-20 | Erlotinib | 1 | uM | 9 | 312.50 | 153.73 | 326.83 | 286.54 | 1.1396 | 1.3231 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 320.83 | 286.54 | 1.1271 | 1.3212 |
| BT-20 | Erlotinib | 10 | uM | 9 | 312.50 | 153.73 | 265.00 | 286.54 | 0.9260 | 0.8374 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 431.17 | 286.54 | 1.5093 | 2.2362 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 825.83 | 794.79 | 1.0387 | 1.0571 |